Hoth Therapeutics Soars 10.46% on Bullish Sentiment

On June 5, 2025, Hoth Therapeutics' stock surged by 10.46% in pre-market trading, indicating a significant bullish sentiment among investors.

Analysts have shown a positive outlook on Hoth Therapeutics, with a consensus rating of "Buy" and an average target price of $4.00. This optimistic view is supported by the company's strong signals, although some analysts still caution that these signals may not be sufficient for a buy recommendation.

Over the past six years, Hoth Therapeutics has experienced a substantial decline in stock value, with an annualized return of -59.65%. Despite this, the recent pre-market surge suggests a potential turnaround in investor sentiment.